96 related articles for article (PubMed ID: 444276)
1. Enzyme pattern-directed chemotherapy. Effects of antipyrimidine combinations on the ribonucleotide content of hepatomas.
Lui MS; Jackson RC; Weber G
Biochem Pharmacol; 1979 Apr; 28(7):1189-95. PubMed ID: 444276
[No Abstract] [Full Text] [Related]
2. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine.
Jackson RC; Williams JC; Weber G
Cancer Treat Rep; 1976 Jul; 60(7):835-43. PubMed ID: 188552
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
4. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Moriconi WJ; Slavik M; Taylor S
Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
[TBL] [Abstract][Full Text] [Related]
5. Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with D-galactosamine and 6-azauridine or N-(phosphonacetyl)-L-aspartate.
Anukarahanonta T; Holstege A; Keppler DO
Eur J Cancer (1965); 1980 Sep; 16(9):1171-80. PubMed ID: 6164559
[No Abstract] [Full Text] [Related]
6. Dietary and metabolic manipulations of the carcinogenic process: role of nucleotide pool imbalances in carcinogenesis.
Rao PM; Laconi E; Vasudevan S; Denda A; Rajagopal S; Rajalakshmi S; Sarma DS
Toxicol Pathol; 1987; 15(2):190-3. PubMed ID: 2887029
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
[TBL] [Abstract][Full Text] [Related]
8. The effects of nucleoside analogs on cutaneous neoplasms.
Klein E; Burgess GH; Bloch A; Milgrom H; Holtermann OA
Ann N Y Acad Sci; 1975 Aug; 255():216-24. PubMed ID: 1059357
[No Abstract] [Full Text] [Related]
9. The regulation of thymidylate biosynthesis in Novikoff hepatoma cells and the effects of amethopterin, 5-fluorodeoxyuridine, and 3-deazauridine.
Jackson RC
J Biol Chem; 1978 Oct; 253(20):7440-6. PubMed ID: 151682
[No Abstract] [Full Text] [Related]
10. Increased formation of nucleotide derivatives of 5-fluorouridine in hepatoma cells treated with inhibitors of pyrimidine synthesis and D-galactosamine.
Holstege A; Herrmann B; Keppler DO
FEBS Lett; 1978 Nov; 95(2):361-5. PubMed ID: 720629
[No Abstract] [Full Text] [Related]
11. Biochemical programs and enzyme-pattern-targeted chemotherapy in cancer cells.
Weber G; Olah E; Lui MS; Tzeng D
Adv Enzyme Regul; 1978; 17():1-21. PubMed ID: 757309
[No Abstract] [Full Text] [Related]
12. Pharmacological and biochemical effects of pyrazofurin in humans.
Ohnuma T; Roboz J; Shapiro ML; Holland JF
Cancer Res; 1977 Jul; 37(7 Pt 1):2043-9. PubMed ID: 861933
[No Abstract] [Full Text] [Related]
13. Pyrazofurin-resistant hepatoma cells deficient in adenosine kinase.
Suttle DP; Harkrader RJ; Jackson RC
Eur J Cancer (1965); 1981 Jan; 17(1):43-51. PubMed ID: 6167445
[No Abstract] [Full Text] [Related]
14. Toxicity of combinations of arabinosylcytosine and 3-deazauridine toward neoplastic cells in culture.
Mills-Yamamoto C; Lauzon GJ; Paterson AR
Biochem Pharmacol; 1978 Jan; 27(2):181-6. PubMed ID: 623673
[No Abstract] [Full Text] [Related]
15. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
Grant S; Cadman E
Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.
Konishi Y; Shinozuka H; Farber JL
Lab Invest; 1974 Jun; 30(6):751-6. PubMed ID: 4835601
[No Abstract] [Full Text] [Related]
17. Recent advances in the design of anticancer chemotherapy.
Weber G
Oncology; 1980; 37 Suppl 1():19-24. PubMed ID: 7454198
[TBL] [Abstract][Full Text] [Related]
18. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K
Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863
[No Abstract] [Full Text] [Related]
19. The effect of 3-deazauridine and dipyridamole on uridine utilization by mice.
Moyer JD; Malinowski N; Cysyk RL
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):323-7. PubMed ID: 2423341
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide contents of ascites hepatoma cells and their changes induced by D-galactosamine.
Keppler DO; Smith DF
Cancer Res; 1974 Apr; 34(4):705-11. PubMed ID: 4360835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
